Description

Linagliptin Film-Coated Tablets (5 mg)

Healthy Inc is a specialized global supplier and exporter of advanced endocrinology, metabolic-support, and diabetic care therapeutics. We provide ultra-high-purity, kinetically precise Linagliptin Film-Coated Tablets (5 mg), manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This “Next-Generation DPP-4 Inhibitor” is a massive-volume, highly lucrative export to diabetic care clinics, endocrinology centers, nephrology networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, renal-safe intervention for glycemic control in adult patients with Type 2 Diabetes Mellitus.

Product Overview

This highly advanced formulation utilizes an intelligent, glucose-dependent mechanism to lower blood sugar. Instead of forcing the pancreas to blindly pump out insulin (which causes dangerous crashes), it simply amplifies the body’s natural metabolic hormones exactly when they are needed.

The “Incretin Amplifier & Renal-Safe” Specialist:

• Mechanism 1 (The DPP-4 Enzymatic Blockade): When a patient eats, the gut releases “incretin” hormones (GLP-1 and GIP) that tell the pancreas to produce insulin. Normally, an enzyme called Dipeptidyl Peptidase-4 (DPP-4) destroys these hormones within minutes. Linagliptin violently binds to and blocks the DPP-4 enzyme. This allows the natural incretin hormones to survive much longer, significantly boosting insulin release and suppressing glucagon (which stops the liver from dumping excess sugar into the blood).
• Mechanism 2 (Glucose-Dependent Safety): Because Linagliptin relies on the body’s natural incretins, it only lowers blood sugar when blood sugar is actually high (after a meal). Once blood glucose returns to normal, the insulin stimulation stops. This provides a massive clinical advantage: unlike older sulfonylureas (like Glimepiride), Linagliptin carries an almost zero risk of causing severe, life-threatening hypoglycemia (low blood sugar).
• Mechanism 3 (The Biliary Excretion Paradigm – CRITICAL): Up to 40% of all Type 2 Diabetics eventually develop Chronic Kidney Disease (CKD). Older gliptins are cleared by the kidneys, requiring constant blood tests and complicated dose reductions to prevent toxicity. Linagliptin is primarily eliminated via the enterohepatic system (feces). Therefore, the 5 mg dose remains perfectly safe and universally effective even in patients with End-Stage Renal Disease (ESRD) or those on dialysis.

Product Composition & Strength

We supply this product as a Precision-Blended, Moisture-Shielded Film-Coated Tablet, packed exclusively in highly secure Alu-Alu blister strips to ensure the absolute chemical stability of the delicate API.

*Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, massive-volume chronic diabetic dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Endocrinology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Micro-Dose Precision & Environmental Shielding (CRITICAL COMPLIANCE): Distributing a 5 mg active payload evenly throughout a standard-sized tablet requires elite thermodynamic and blending controls. If a diabetic tablet lacks content uniformity, the patient’s HbA1c levels will swing wildly. Our facilities utilize advanced high-shear dry blending and geometric dilution under strictly controlled humidity environments (RH < 40%). This guarantees flawless Content Uniformity (CU) and absolute clinical reliability for long-term metabolic management.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly specialized management of metabolic dysfunction:

• Type 2 Diabetes Mellitus: Used as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes.
• Monotherapy or Combination: Highly effective as monotherapy (if Metformin is contraindicated) or in combination with Metformin, Sulfonylureas, or Pioglitazone.
• Diabetic Nephropathy / CKD: The absolute drug of choice for diabetics suffering from concurrent, severe kidney disease where other oral antidiabetics are fatally toxic.

Dosage & Administration

Recommended Dosage (Strictly as per Endocrinologist Guidelines):

• Standard Adult Dosing: 5 mg taken orally once daily.
• Dose Adjustment: NO dose adjustment is required for patients with renal impairment, hepatic impairment, or the elderly.
• Administration: Can be taken with or without food, at any time of the day, making it one of the most compliant diabetic medications on the market.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Acute Pancreatitis (Clinical Alert): Post-marketing reports have identified a rare but severe risk of acute, potentially fatal pancreatitis. Patients must be counseled to stop the drug and seek emergency care if they experience severe, persistent abdominal pain radiating to the back.
• Severe and Disabling Arthralgia: The DPP-4 inhibitor class has been linked to severe, disabling joint pain that can occur from one day to years after starting therapy. Relief typically occurs upon discontinuation.
• Bullous Pemphigoid: Rare cases of severe, blistering skin reactions requiring hospitalization and immunosuppressive treatment have been reported.
• Heart Failure Caution: While Linagliptin has a highly favorable cardiovascular safety profile compared to older drugs, physicians should observe patients for signs and symptoms of heart failure during therapy.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Diabetic Care Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antidiabetics, Micro-Dosed Formulations, and Renal-Safe Therapeutics. Whether you are looking for a reliable Government Tender Supplier for metabolic clinics in Africa or a B2B Pharma Marketplace partner for Latin America, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.